Evidence map›Paper›PMID 29351990›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.

Magdolna Djurec, Osvaldo Graña, Albert Lee, Kevin Troulé, Elisa Espinet, Lavinia Cabras, Carolina Navas, María Teresa Blasco, Laura Martín-Díaz, Miranda Burdiel and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Nuclear Galectin-1 promotesProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Magdolna DjurecMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
Osvaldo GrañaBioinformatics Unit, Structural Biology and Biocomputing Programmes, CNIO, 28029 Madrid, Spain.
Albert LeeDepartment of Systems Biology, Columbia University Medical Center, New York, NY 10032.
Kevin TrouléBioinformatics Unit, Structural Biology and Biocomputing Programmes, CNIO, 28029 Madrid, Spain.
Elisa EspinetDivison of Stem Cells and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Lavinia CabrasMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
Carolina NavasMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
María Teresa BlascoMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
Laura Martín-DíazMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
Miranda BurdielMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
Jing LiMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
Zhaoqi LiuDepartment of Systems Biology, Columbia University Medical Center, New York, NY 10032.
Mireia VallespinósDepartment of Biochemistry, School of Medicine, Autonomous University of Madrid, 28018 Madrid, Spain.
Francisco Sanchez-BuenoDepartment of Surgery, Clinical University Hospital Virgen Arrixaca, Murcian Institute of Biomedical Investigation (IMIB), 30120 Murcia, Spain.
Martin R SprickHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany.
Andreas TrumppDivison of Stem Cells and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Bruno SainzDepartment of Biochemistry, School of Medicine, Autonomous University of Madrid, 28018 Madrid, Spain.ORCID 0000-0003-4829-7651
Fátima Al-ShahrourBioinformatics Unit, Structural Biology and Biocomputing Programmes, CNIO, 28029 Madrid, Spain.
Raul RabadanDepartment of Systems Biology, Columbia University Medical Center, New York, NY 10032.
Carmen GuerraMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; mcguerra@cnio.es mbarbacid@cnio.es.
Mariano BarbacidMolecular Oncology, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; mcguerra@cnio.es mbarbacid@cnio.es.
Spanish National Cancer Research Centre · ESColumbia University Irving Medical Center · USGerman Cancer Research Center · DEInstituto Ramón y Cajal de Investigación Sanitaria · ESHeidelberg Institute for Stem Cell Technology and Experimental Medicine · DEInstituto Murciano de Investigación Biosanitaria · ES

Funding

European Research Council 250297
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by the presence of abundant desmoplastic stroma primarily composed of cancer-associated fibroblasts (CAFs). It is generally accepted that CAFs stimulate tumor progression and might be implicated in drug resistance and immunosuppression. Here, we have compared the transcriptional profile of PDGFRα

Indexed as

AnimalsCancer-Associated FibroblastsCarcinoma, Pancreatic DuctalCell MovementCell ProliferationFemaleHigh-Throughput Nucleotide SequencingHumansMiceMice, Inbred C57BLMice, KnockoutPancreasPancreatic NeoplasmsSerum Amyloid A ProteinStromal CellsTumor MicroenvironmentSAA1 protein, humanSAA3P protein, humanSaa3 protein, mouseSerum Amyloid A ProteinCAFsmouse modelsPDACSaa3stroma

Identifiers

PMID29351990
PMCPMC5819438
OpenAlexW2783528540

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.